Equities analysts expect that Lannett Company, Inc. (NYSE:LCI) will report sales of $162.91 million for the current fiscal quarter, Zacks reports. Five analysts have made estimates for Lannett Company’s earnings, with the lowest sales estimate coming in at $160.8 million and the highest estimate coming in at $165.1 million. Lannett Company reported sales of $168.89 million during the same quarter last year, which would suggest a negative year over year growth rate of 3.5%. The firm is scheduled to report its next earnings results on Tuesday, August 22nd.

According to Zacks, analysts expect that Lannett Company will report full year sales of $162.91 million for the current year, with estimates ranging from $659.02 million to $663.3 million. For the next fiscal year, analysts expect that the firm will report sales of $650.27 million per share, with estimates ranging from $636.13 million to $677.4 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for Lannett Company.

Lannett Company (NYSE:LCI) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $0.77 EPS for the quarter, missing the consensus estimate of $0.87 by $0.10. Lannett Company had a negative net margin of 3.48% and a positive return on equity of 21.95%. The company had revenue of $165.72 million for the quarter, compared to analyst estimates of $170.28 million.

Several research analysts have weighed in on LCI shares. Zacks Investment Research lowered Lannett Company from a “buy” rating to a “hold” rating in a research report on Friday, March 24th. BMO Capital Markets started coverage on Lannett Company in a research report on Monday, May 1st. They set a “market perform” rating and a $29.00 price target on the stock. Roth Capital set a $28.00 price target on Lannett Company and gave the stock a “buy” rating in a research report on Thursday, February 2nd. Robert W. Baird reaffirmed an “outperform” rating and set a $18.00 price target on shares of Lannett Company in a research report on Wednesday, May 3rd. Finally, Oppenheimer Holdings Inc. reaffirmed a “hold” rating on shares of Lannett Company in a research report on Tuesday, May 2nd. Five research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $28.33.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Credit Suisse AG raised its position in Lannett Company by 10.9% in the first quarter. Credit Suisse AG now owns 39,491 shares of the company’s stock worth $883,000 after buying an additional 3,892 shares during the last quarter. Tudor Investment Corp ET AL raised its position in Lannett Company by 49.5% in the first quarter. Tudor Investment Corp ET AL now owns 14,800 shares of the company’s stock worth $331,000 after buying an additional 4,900 shares during the last quarter. Westwood Holdings Group Inc. raised its position in Lannett Company by 22.5% in the first quarter. Westwood Holdings Group Inc. now owns 181,832 shares of the company’s stock worth $4,064,000 after buying an additional 33,340 shares during the last quarter. Gotham Asset Management LLC raised its position in Lannett Company by 12.4% in the first quarter. Gotham Asset Management LLC now owns 695,498 shares of the company’s stock worth $15,544,000 after buying an additional 76,892 shares during the last quarter. Finally, Highbridge Capital Management LLC acquired a new position in Lannett Company during the first quarter worth $287,000. 80.82% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Brokerages Expect Lannett Company, Inc. (LCI) Will Post Quarterly Sales of $162.91 Million” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/05/17/brokerages-expect-lannett-company-inc-lci-will-post-quarterly-sales-of-162-91-million.html.

Shares of Lannett Company (NYSE:LCI) traded down 2.494% during trading on Wednesday, reaching $20.525. The company’s stock had a trading volume of 345,374 shares. The company’s market cap is $764.15 million. Lannett Company has a 52 week low of $16.75 and a 52 week high of $39.99. The stock’s 50 day moving average price is $23.68 and its 200 day moving average price is $22.34.

Lannett Company Company Profile

Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.

5 Day Chart for NYSE:LCI

Get a free copy of the Zacks research report on Lannett Company (LCI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Lannett Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.